1.298  -0.012 (-0.92%)		10-24 14:57
Open: 1.295 High: 1.31 Volume: 54,321		Pre. Close: 1.31 Low: 1.28 Market Cap: 20(M)

Short term
Mid term
Targets	6-month :	2.42	1-year :	3.01
Resists	First :	2.07	Second :	2.58
Pivot price	1.71
Supports	First :	1.25	Second :	1.03
MAs	MA(5) :	1.36	MA(20) :	1.78
	MA(100) :	1.52	MA(250) :	1.47
MACD	MACD :	-0.2	Signal :	-0.1
%K %D	K(14,3) :	4.2	D(3) :	5.8
RSI	RSI(14): 36.9
52-week	High :	4.19	Low :	0.62

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ ADGM ] has closed above bottom band by 23.9%. Bollinger Bands are 163.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	1.36 - 1.37	1.37 - 1.38
Low:	1.23 - 1.24	1.24 - 1.25
Close:	1.29 - 1.31	1.31 - 1.33

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.

Tue, 21 Oct 2025
Adagio Medical closes $50 million private placement to fund FDA efforts - Investing.com

Mon, 20 Oct 2025
Adagio Medical Reports Promising Results from FULCRUM-VT Study - MSN

Mon, 20 Oct 2025
[424B3] Adagio Medical Holdings, Inc. Prospectus Filed Pursuant to Rule 424(b)(3) - Stock Titan

Mon, 20 Oct 2025
ADGM - Adagio Medical Latest Stock News & Market Updates - Stock Titan

Mon, 20 Oct 2025
Adagio Medical Holdings, Inc. Closes $19 Million Financing - TradingView

Mon, 20 Oct 2025
$19M Upfront Funds: Adagio Medical Advances vCLAS ULTC, Supports FULCRUM-VT FDA Submission - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	0 (M)
Shares Float	15 (M)
Held by Insiders	2.29e+006 (%)
Held by Institutions	0.2 (%)
Shares Short	144 (K)
Shares Short P.Month	0 (K)

EPS	-3.034e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-9 %
Return on Assets (ttm)	840 %
Return on Equity (ttm)	-90.2 %
Qtrly Rev. Growth	322000 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-1.31667e+007
Qtrly Earnings Growth	-4.6 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-28 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0.42

Dividend	0
Forward Dividend	209060
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.